Christine Bray, Ovarian Cancer Patient Story Ovarian cancer survivor Christine Bray was looking for new options. Her body was resistant to the chemotherapy drug she had initially taken, so she wanted an approach that “looked outside the box.” Justin Chura, MD, Chief of Surgery and Director of Gynecologic Oncology and Robotic Surgery at Cancer Treatment Centers of America (CTCA) in Philadelphia, explained the potential benefits of genomic testing, which analyzes the DNA mutations in the tumor itself to help identify potential treatments. Watch the video to find out how Bray is doing today. To learn more about genomic testing, visit: Read more patients testimonials at